PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage "PICASSO"
Recruiting
Phase 4 Results N/AEligibility Criteria
Inclusion Criteria
- Clinical diagnosis of ischemic stroke within 120 days- Adult aged 20 years or older
- High risk of hemorrhagic stroke (history of intracranial hemorrhage or imaging evidence of previous intracranial hemorrhage)
- Informed consent
Exclusion Criteria
- Clinical diagnosis of myocardial infarction or coronary intervention within 4 weeks- Bleeding tendency
- Pregnant or breast-feeding woman
- Hemorrhagic stroke within 6 months
- Patient who was taking antithrombotic medication other than aspirin and does not agree to change the previous medication
- Severe cardiovascular disease such as cardiomyopathy or congestive heart failure
- Life expectancy less than one year
- Contraindication to long term aspirin use
- Enrolled in other clinical trial within 30 days
View Trial Locations
Recruitment
- Enrollment: 1,592
- Gender: Both
- Minimum Age: 20 Years
- Accepts Healthy Volunteers: No
- 77 locations, 2 countries
Principal Investigator
- Sun U. Kwon, MD, PhD
Departement of Neurology, Asan Medical Center
